Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardian Pharmacy Services (GRDN) EBITDA Margin (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed EBITDA Margin for 3 consecutive years, with 7.74% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 279.0% to 7.74% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.02% through Dec 2025, up 1014.0% year-over-year, with the annual reading at 5.02% for FY2025, 1014.0% up from the prior year.
  • EBITDA Margin hit 7.74% in Q4 2025 for Guardian Pharmacy Services, up from 4.33% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 7.74% in Q4 2025 to a low of 33.27% in Q3 2024.
  • Historically, EBITDA Margin has averaged 0.3% across 3 years, with a median of 4.14% in 2025.
  • Biggest five-year swings in EBITDA Margin: tumbled -3087bps in 2024 and later soared 3761bps in 2025.
  • Year by year, EBITDA Margin stood at 5.52% in 2023, then dropped by -10bps to 4.95% in 2024, then skyrocketed by 56bps to 7.74% in 2025.
  • Business Quant data shows EBITDA Margin for GRDN at 7.74% in Q4 2025, 4.33% in Q3 2025, and 3.65% in Q2 2025.